c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism P Gao, I Tchernyshyov, TC Chang, YS Lee, K Kita, T Ochi, KI Zeller, ... Nature 458 (7239), 762-765, 2009 | 2286 | 2009 |
Widespread microRNA repression by Myc contributes to tumorigenesis TC Chang, D Yu, YS Lee, EA Wentzel, DE Arking, KM West, CV Dang, ... Nature genetics 40 (1), 43-50, 2008 | 1666 | 2008 |
Regulation of muscle mass by follistatin and activins SJ Lee, YS Lee, TA Zimmers, A Soleimani, MM Matzuk, K Tsuchida, ... Molecular endocrinology 24 (10), 1998-2008, 2010 | 331 | 2010 |
Role of satellite cells versus myofibers in muscle hypertrophy induced by inhibition of the myostatin/activin signaling pathway SJ Lee, TV Huynh, YS Lee, SM Sebald, SA Wilcox-Adelman, N Iwamori, ... Proceedings of the National Academy of Sciences 109 (35), E2353-E2360, 2012 | 191 | 2012 |
Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs YS Lee, H Kim, TX Wu, XM Wang, RA Dionne Clinical Pharmacology & Therapeutics 79 (5), 407-418, 2006 | 178 | 2006 |
Regulation of GDF-11 and myostatin activity by GASP-1 and GASP-2 YS Lee, SJ Lee Proceedings of the National Academy of Sciences 110 (39), E3713-E3722, 2013 | 132 | 2013 |
Acetaminophen selectively suppresses peripheral prostaglandin E2 release and increases COX-2 gene expression in a clinical model of acute inflammation YS Lee, H Kim, JS Brahim, J Rowan, G Lee, RA Dionne Pain 129 (3), 279-286, 2007 | 112 | 2007 |
The role of COX-2 in acute pain and the use of selective COX-2 inhibitors for acute pain relief Y Lee, C Rodriguez, RA Dionne Current pharmaceutical design 11 (14), 1737-1755, 2005 | 107 | 2005 |
Effects of the fibrous topography-mediated macrophage phenotype transition on the recruitment of mesenchymal stem cells: an in vivo study Q Zhang, JW Hwang, JH Oh, CH Park, SH Chung, YS Lee, JH Baek, ... Biomaterials 149, 77-87, 2017 | 65 | 2017 |
GDF11 promotes osteogenesis as opposed to MSTN, and follistatin, a MSTN/GDF11 inhibitor, increases muscle mass but weakens bone J Suh, NK Kim, SH Lee, JH Eom, Y Lee, JC Park, KM Woo, JH Baek, ... Proceedings of the National Academy of Sciences 117 (9), 4910-4920, 2020 | 61 | 2020 |
Myostatin inhibitors: panacea or predicament for musculoskeletal disorders? J Suh, YS Lee Journal of bone metabolism 27 (3), 151, 2020 | 59 | 2020 |
Effects of the incorporation of ε-aminocaproic acid/chitosan particles to fibrin on cementoblast differentiation and cementum regeneration CH Park, JH Oh, HM Jung, Y Choi, SU Rahman, S Kim, TI Kim, HI Shin, ... Acta biomaterialia 61, 134-143, 2017 | 48 | 2017 |
Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy YS Lee, A Lehar, S Sebald, M Liu, KA Swaggart, CC Talbot Jr, P Pytel, ... Human molecular genetics 24 (20), 5711-5719, 2015 | 45 | 2015 |
Paracrine and endocrine modes of myostatin action YS Lee, TV Huynh, SJ Lee Journal of applied physiology 120 (6), 592-598, 2016 | 40 | 2016 |
Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: Implication for the adverse effects of cyclooxygenase‐2 inhibitors XM Wang, TX Wu, YS Lee, RA Dionne Clinical Pharmacology & Therapeutics 79 (4), 303-315, 2006 | 39 | 2006 |
Alternative binding modes identified for growth and differentiation factor-associated serum protein (GASP) family antagonism of myostatin RG Walker, EB Angerman, C Kattamuri, YS Lee, SJ Lee, TB Thompson Journal of Biological Chemistry 290 (12), 7506-7516, 2015 | 38 | 2015 |
Similar sequences but dissimilar biological functions of GDF11 and myostatin J Suh, YS Lee Experimental & molecular medicine 52 (10), 1673-1693, 2020 | 31 | 2020 |
Mitochondrial fragmentation and donut formation enhance mitochondrial secretion to promote osteogenesis J Suh, NK Kim, W Shim, SH Lee, HJ Kim, E Moon, H Sesaki, JH Jang, ... Cell metabolism 35 (2), 345-360. e7, 2023 | 28 | 2023 |
Interaction of fibromodulin and myostatin to regulate skeletal muscle aging: an opposite regulation in muscle aging, diabetes, and intracellular lipid accumulation EJ Lee, SS Ahmad, JH Lim, K Ahmad, S Shaikh, YS Lee, SJ Park, JO Jin, ... Cells 10 (8), 2083, 2021 | 26 | 2021 |
PIN1 is a new therapeutic target of craniosynostosis HR Shin, HS Bae, BS Kim, HI Yoon, YD Cho, WJ Kim, KY Choi, YS Lee, ... Human Molecular Genetics 27 (22), 3827-3839, 2018 | 23 | 2018 |